Add to ORKGDr. DuBois begins this chapter by explaining how he was led to take a faculty position at Vanderbilt University in 1991, and where he would stay for sixteen years.2 He first talks about how he continued his research, leading to the discovery that COX-2 played a role in cancer and that it could be inhibited. This work was published in Cell in 1993, and helped him make his name.https://openworks.mdanderson.org/mchv_interviewchapters/1658/thumbnail.jp
Dr. DuBois begins this chapter by noting that in \u2779-\u2780 he had a vision of how basic sciences...
Dr. Bast begins this chapter by reviewing his reasons for leaving his role as head of the cancer cen...
Dr. Dmitrovsky begins this chapter by noting that his successful study of DMSO and the c-Myk oncogen...
Dr. DuBois begins this chapter by explaining how he was led to take a faculty position at Vanderbilt...
In this chapter, Dr. DuBois talks about the latest evolution of his research into cancer interruptio...
In this chapter, Dr. DuBois explains that when he began college at Texas A & M University, he soon r...
Interest in Cancer: Dr. Knudson continues outlining his path towards discovering the two-hit model. ...
Dr. Mills begins this chapter by explaining that as cancer research evolved in the nineties, it beca...
In this chapter, begins to discuss his research contributions. He first notes that he met Dr. Judah...
Dr. Tomasovic begins this segment with comments on MD Anderson’s perceived weaknesses in basic resea...
Dr. Arlinghaus explains his reasons for focusing on leukemia research and the process of coming to M...
In this chapter, Dr. Dmitrovsky talks about the research project that would set him on the path to d...
Dr. DuBois begins this chapter with a few additional comments about his decision to leave his positi...
Dr. Dmitrovsky begins this chapter by explaining how he selected Harvard University for his undergra...
Dr. Bast explains how his desire to integrate research into his clinical practice evolved in medical...
Dr. DuBois begins this chapter by noting that in \u2779-\u2780 he had a vision of how basic sciences...
Dr. Bast begins this chapter by reviewing his reasons for leaving his role as head of the cancer cen...
Dr. Dmitrovsky begins this chapter by noting that his successful study of DMSO and the c-Myk oncogen...
Dr. DuBois begins this chapter by explaining how he was led to take a faculty position at Vanderbilt...
In this chapter, Dr. DuBois talks about the latest evolution of his research into cancer interruptio...
In this chapter, Dr. DuBois explains that when he began college at Texas A & M University, he soon r...
Interest in Cancer: Dr. Knudson continues outlining his path towards discovering the two-hit model. ...
Dr. Mills begins this chapter by explaining that as cancer research evolved in the nineties, it beca...
In this chapter, begins to discuss his research contributions. He first notes that he met Dr. Judah...
Dr. Tomasovic begins this segment with comments on MD Anderson’s perceived weaknesses in basic resea...
Dr. Arlinghaus explains his reasons for focusing on leukemia research and the process of coming to M...
In this chapter, Dr. Dmitrovsky talks about the research project that would set him on the path to d...
Dr. DuBois begins this chapter with a few additional comments about his decision to leave his positi...
Dr. Dmitrovsky begins this chapter by explaining how he selected Harvard University for his undergra...
Dr. Bast explains how his desire to integrate research into his clinical practice evolved in medical...
Dr. DuBois begins this chapter by noting that in \u2779-\u2780 he had a vision of how basic sciences...
Dr. Bast begins this chapter by reviewing his reasons for leaving his role as head of the cancer cen...
Dr. Dmitrovsky begins this chapter by noting that his successful study of DMSO and the c-Myk oncogen...